Dow Down 0.68% Nasdaq Down 0.42%

Nymox Pharmaceutical Corporation (NYMX)

-NasdaqCM
3.99 Down 0.25(5.90%) 4:00PM EDT
Prev Close:4.24
Open:4.23
Bid:3.94 x 100
Ask:3.99 x 800
1y Target Est:9.90
Beta:0.47
Next Earnings Date:N/A
Day's Range:3.95 - 4.23
52wk Range:3.81 - 7.90
Volume:120,128
Avg Vol (3m):55,663
Market Cap:141.25M
P/E (ttm):N/A
EPS (ttm):-0.19
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for NYMX

Comparison

Symbol% ChgMkt Cap
NYMXDown 5.90%141.25M
ABTDown 2.07%63.91B
LHDown 1.47%8.74B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):47.42
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.20
Quarterly EPS Est (Mar-14) :N/A
Mean Recommendation*:1.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Nymox Pharmaceutical Corporation, a biopharmaceutical company, is engaged in the research and development of products for the aging population. It provides NicAlert and TobacAlert products that use urine or saliva to detect use of and exposure to ... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback